Trial intelligence / Profile preview

Oxytocin Dose-finding in Elective Cesarean Deliveries (BMI ≥ 40kg/m2)

NCT03957083Completed

Sponsor
Mount Sinai Hospital
Start
Jun 2019
Primary completion
Feb 2020
Modality
Peptides
Countries
1
01

Overview

Randomised, double-blind trial of oxytocin in postpartum hemorrhage (PPH) (6 arms), sponsored by Mount Sinai Hospital. Primary endpoint: Uterine tone at 2 minutes. Started Jun 2019; status: completed.

02

Drugs

oxytocin
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on NCT03957083.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03957083.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call